Biosan Medical Receives U.S. Patent for Its Novel Device and Method of Treating the Deadliest Type of Stroke, Subarachnoid Hemorrhage (SAH), and Alzheimer’s Disease
7/22/2013 9:36:08 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TEL AVIV, Israel--(BUSINESS WIRE)--Biosan Medical, an emerging medical device company, announced today that it has been issued U.S. Provisional Patent No. 61,957,293 for its revolutionary Ventritek105® Stroke Treatment Device and Method (“Device & method for CSF auto-transfusion therapy for the treatment of SAH (subarachnoid hemorrhage), Alzheimer’s Disease & other Neuro-Degenerative CNS diseases”).
Help employers find you! Check out all the jobs and post your resume.
comments powered by